0 items USD 0.00Search
Your search for "gbi research non small cell lung cancer market 2020 new therapies enhance treatment segmentation" gave back 679711 results.
The global Drugs for Non-Small Cell Lung Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Small Cell Lung Cancer Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Ensartinib Hydrochloride market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
December 2023
Price: USD 4,480.00
The global Ensartinib Hydrochloride market size was valued at US$ million in 2022. With growing demand in downstream market, the Ensartinib...
Catalog:
LPI
December 2023
Price: USD 3,660.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Ensartinib Hydrochloride market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global Squamous Non-Small Cell Lung Cancer Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market,...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Non-small Cell Lung Cancer Therapeutics market was valued at US$ 9067 million in 2023 and is anticipated to reach US$ 14010 million by...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Squamous Non-Small Cell Lung Cancer Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
